Mithunah Krishnamoorthy

Mithunah Krishnamoorthy, PhD, is a Senior Scientist at Pfizer Inc., specializing in the design and execution of functional assays in immune cells. Previously, they served as a Postdoctoral Fellow in Translational Immuno-Oncology at both London Health Sciences Centre and Trillium Therapeutics Inc., where they conducted groundbreaking research on the SIRPαFC (CD47 blocker) and its effects on T cell proliferation. They completed their Doctor of Philosophy in Immunology at the University of Toronto, where they also held positions as a Teaching Assistant and Doctoral Candidate, publishing significant findings in high-impact journals. Throughout their career, Mithunah has demonstrated a strong commitment to problem-solving, collaboration, and mentoring.